The Economist (US), March 19th, 1988
ECSTASY poses problems. The drug rejoicing in that name, a cross between mescalin and amphetamine, has both pleasant and unpleasant effects. It seems to warrant its name, but can leave a nasty hangover and may also damage people's brains. Caution-and America's Drug Enforcement Administration (DEA)-therefore speak against it. Both may be speaking too soon. The drug (known to pharmacologists as MDMA) was patented in 1914 by a German drug company, Merck, as an appetite suppressant. Its legal troubles began in 1984 after American students cooked it up in makeshift laboratories and found other us...
HighBeam Research, Free Preview: 'Ignorance of bliss. (psychoactive drugs)'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.